NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice

NCT01893268

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Non-Squamous Non-Small Cell Lung Cancer

Countries: France

This prospective, observational study will assess the effectiveness and safety of Avastin (bevacizumab) as 1st line therapy in elderly patients with advanced non-squamous non-small cell lung cancer in clinical practice. Therapy with Avastin and standard chemotherapy will be administered according to the treating physician. Data will be collected for approximately 4 years.

Eligibility overview

Sex: ALL

Age: 65 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Adult patients, \>= 65 years of age
* Diagnosis of advanced non squamous Non-Small Cell Lung Carcinoma (nsNSCLC, stage IIIB or IV) for whom the physician has decided to initiate a treatment with Avastin combined with chemotherapy as 1st line therapy
* Having received oral and written information about the study, and having signed a written consent form

Exclusion Criteria:

* Participation in a cancer clinical trial with an investigational medicinal product other than this study
* Patient previously treated with Avastin
* Patient under supervision or guardianship

Locations (88)

Agen, France
Aix-en-Provence, France
Aix-en-Provence, France
Amiens, France
Angers, France
Bayonne, France
Besançon, France
Beuvry, France
Béziers, France
Bobigny, France
Bordeaux, France
Bourg-en-Bresse, France
Bourg-en-Bresse, France
Brest, France
Brive-la-Gaillarde, France
Bron, France
Cannes, France
Carcassonne, France
Castelnau Lez, France
Chalon-sur-Saône, France
Chauny, France
Cherbourg Octeville, France
Clermont-Ferrand, France
Clermont-Ferrand, France
Colmar, France
Contamine-sur-Arve, France
Cornebarrieu, France
Créteil, France
Dijon, France
Draguignan, France
+ 58 more on CT.gov